Evidence map›Paper›PMID 31024461›Full record

ArticleFrontiers in endocrinology2019

Corrigendum: Tetrac and NDAT Induce Anti-proliferation via Integrin αvβ3 in Colorectal Cancers With Different

Yu-Tang Chin, Zong-Rong He, Chi-Long Chen, Hsiao-Ching Chu, Yih Ho, Po-Yu Su, Yu-Chen S H Yang, Kuan Wang, Ya-Jung Shih, Yi-Ru Chen and 8 more

Abstract readPublished Erratum
In one paragraph

Article in Frontiers in endocrinology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Yu-Tang ChinTaipei Cancer Center, Taipei Medical University, Taipei, Taiwan.
Zong-Rong HeDepartment of Pediatrics, E-Da Hospital, Kaohsiung, Taiwan.
Chi-Long ChenSchool of Medicine, Taipei Medical University, Taipei, Taiwan.
Hsiao-Ching ChuDivision of Medical Imaging, E-Da Cancer Hospital, I-Shou University, Kaohsiung, Taiwan.
Yih HoTaipei Cancer Center, Taipei Medical University, Taipei, Taiwan.
Po-Yu SuGraduate Institute of Nanomedicine and Medical Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan.
Yu-Chen S H YangJoint Biobank, Office of Human Research, Taipei Medical University, Taipei, Taiwan.
Kuan WangTaipei Cancer Center, Taipei Medical University, Taipei, Taiwan.
Ya-Jung ShihTaipei Cancer Center, Taipei Medical University, Taipei, Taiwan.
Yi-Ru ChenTaipei Cancer Center, Taipei Medical University, Taipei, Taiwan.
Jens Z PedersenDepartment of Biology, University of Rome Tor Vergata, Rome, Italy.
Sandra IncerpiDepartment of Sciences, Roma Tre University, Rome, Italy.
André Wendindondé NanaGraduate Institute of Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei, Taiwan.
Heng-Yuan TangPharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY, United States.
Hung-Yun LinTaipei Cancer Center, Taipei Medical University, Taipei, Taiwan.
Shaker A MousaPharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY, United States.
Paul J DavisPharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY, United States.
Jacqueline Whang-PengTaipei Cancer Center, Taipei Medical University, Taipei, Taiwan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fendo.2019.00130.].

Indexed as

anticancercolorectal cancer cellsintegrin αvβ3NDATperfusion bellows cell culture systemphosphoERK1/2tetrac

Identifiers

PMID31024461
PMCPMC6465793

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.